(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 3.46% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.74%.
Aptargroup's revenue in 2025 is $3,662,533,000.On average, 10 Wall Street analysts forecast ATR's revenue for 2025 to be $244,496,967,804, with the lowest ATR revenue forecast at $235,769,620,322, and the highest ATR revenue forecast at $255,586,604,830. On average, 10 Wall Street analysts forecast ATR's revenue for 2026 to be $252,764,981,208, with the lowest ATR revenue forecast at $242,528,393,184, and the highest ATR revenue forecast at $267,594,910,012.
In 2027, ATR is forecast to generate $267,463,671,704 in revenue, with the lowest revenue forecast at $251,386,978,974 and the highest revenue forecast at $287,936,847,752.